Angelo Messina

1.0k total citations
26 papers, 773 citations indexed

About

Angelo Messina is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Angelo Messina has authored 26 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Hematology. Recurrent topics in Angelo Messina's work include Viral-associated cancers and disorders (9 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Angelo Messina is often cited by papers focused on Viral-associated cancers and disorders (9 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Angelo Messina collaborates with scholars based in Italy, United States and Poland. Angelo Messina's co-authors include Giorgio Stassi, Paolo Vigneri, James J. Goedert, Elizabeth E. Brown, Denise Whitby, Francesco Vitale, Carmela Lauria, L Messina, Ann Zeuner and Concetta Conticello and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Angelo Messina

25 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Messina Italy 16 402 258 237 97 96 26 773
John C. Minnerly United States 8 232 0.6× 153 0.6× 229 1.0× 66 0.7× 53 0.6× 11 745
Artem Laktyushin Australia 7 498 1.2× 311 1.2× 401 1.7× 59 0.6× 80 0.8× 11 863
Esther P.M. Tjin Netherlands 19 284 0.7× 497 1.9× 461 1.9× 77 0.8× 99 1.0× 33 1.2k
Paola Zancai Italy 13 269 0.7× 242 0.9× 89 0.4× 65 0.7× 217 2.3× 18 516
Nicholas C. Hsu Taiwan 15 236 0.6× 317 1.2× 272 1.1× 120 1.2× 61 0.6× 28 815
Lucía Cabal‐Hierro United States 10 172 0.4× 316 1.2× 270 1.1× 107 1.1× 75 0.8× 16 796
Huihua Zhang China 14 363 0.9× 322 1.2× 151 0.6× 81 0.8× 57 0.6× 38 757
Patrice Hémon France 16 369 0.9× 252 1.0× 513 2.2× 72 0.7× 36 0.4× 29 965
Mark Tsang United States 11 124 0.3× 351 1.4× 197 0.8× 53 0.5× 61 0.6× 15 688
Hirokazu Hirata Japan 10 143 0.4× 589 2.3× 275 1.2× 75 0.8× 43 0.4× 14 834

Countries citing papers authored by Angelo Messina

Since Specialization
Citations

This map shows the geographic impact of Angelo Messina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Messina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Messina more than expected).

Fields of papers citing papers by Angelo Messina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Messina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Messina. The network helps show where Angelo Messina may publish in the future.

Co-authorship network of co-authors of Angelo Messina

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Messina. A scholar is included among the top collaborators of Angelo Messina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Messina. Angelo Messina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Leah, et al.. (2016). The Eaf3/5/7 Subcomplex Stimulates NuA4 Interaction with Methylated Histone H3 Lys-36 and RNA Polymerase II. Journal of Biological Chemistry. 291(40). 21195–21207. 16 indexed citations
2.
Goedert, James J., Giuseppe Calamusa, Carmelo Dazzi, et al.. (2010). Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily. Infectious Agents and Cancer. 5(1). 23–23. 8 indexed citations
3.
D’Asaro, Matilde, Carmela La Mendola, Diana Di Liberto, et al.. (2010). Vγ9Vδ2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells. The Journal of Immunology. 184(6). 3260–3268. 117 indexed citations
4.
Pelser, Colleen, Jaap M. Middeldorp, Sam M. Mbulaiteye, et al.. (2010). Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30. Infectious Agents and Cancer. 5(1). 18–18. 3 indexed citations
5.
Stagno, Fabio, Paolo Vigneri, Vittorio Del Fabro, et al.. (2009). Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias. Acta Oncologica. 49(1). 111–112. 10 indexed citations
6.
Pelser, Colleen, Francesco Vitale, Denise Whitby, et al.. (2009). Socio‐economic and other correlates of Kaposi sarcoma‐associated herpesvirus seroprevalence among older adults in Sicily. Journal of Medical Virology. 81(11). 1938–1944. 7 indexed citations
7.
Manzella, Livia, et al.. (2007). Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded. Proteins Structure Function and Bioinformatics. 67(1). 1–11. 4 indexed citations
8.
Brown, Elizabeth E., Denise Whitby, Francesco Vitale, et al.. (2006). Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. Cancer. 107(9). 2282–2290. 44 indexed citations
9.
Brown, Elizabeth E., M. Daniele Fallin, James J. Goedert, et al.. (2006). Host Immunogenetics and Control of Human Herpesvirus–8 Infection. The Journal of Infectious Diseases. 193(8). 1054–1062. 25 indexed citations
10.
Tirrò, Elena, Michele Massimino, Livia Manzella, et al.. (2006). Altered Expression of c-IAP1, Survivin, and Smac Contributes to Chemotherapy Resistance in Thyroid Cancer Cells. Cancer Research. 66(8). 4263–4272. 80 indexed citations
11.
Brown, Elizabeth E., Denise Whitby, Francesco Vitale, et al.. (2005). Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma. International Journal of Epidemiology. 34(5). 1110–1117. 18 indexed citations
12.
Aloisi, Alessandra, Sandra Di Gregorio, Fabio Stagno, et al.. (2005). BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B. Blood. 107(4). 1591–1598. 46 indexed citations
13.
Brown, Elizabeth E., M. Daniele Fallin, James J. Goedert, et al.. (2005). A Common Genetic Variant inFCGR3A-V158F and Risk of Kaposi Sarcoma Herpesvirus Infection and Classic Kaposi Sarcoma. Cancer Epidemiology Biomarkers & Prevention. 14(3). 633–637. 15 indexed citations
14.
Conticello, Concetta, Francesca Pedini, Ann Zeuner, et al.. (2004). IL-4 Protects Tumor Cells from Anti-CD95 and Chemotherapeutic Agents via Up-Regulation of Antiapoptotic Proteins. The Journal of Immunology. 172(9). 5467–5477. 128 indexed citations
15.
Conte, Enrico, et al.. (2004). Survivin expression in chronic myeloid leukemia. Cancer Letters. 225(1). 105–110. 30 indexed citations
16.
Pignatello, Rosario, Antonina Puleo, Giovanni Puglisi, Luisa Vicari, & Angelo Messina. (2003). Effect of Liposomal Delivery on In Vitro Antitumor Activity of Lipophilic Conjugates of Methotrexate with Lipoamino Acids. Drug Delivery. 10(2). 95–100. 12 indexed citations
17.
Manzella, Livia, et al.. (1999). Role of interferon regulatory factor 1 in monocyte/macrophage differentiation. European Journal of Immunology. 29(9). 3009–3016. 16 indexed citations
18.
19.
20.
Messina, L, Antonio Arcidiacono, Lucia Malaguarnera, et al.. (1990). Accumulation of ornithine decarboxylase mRNA accompanies activation of human and mouse monocytes/macrophages. FEBS Letters. 268(1). 32–34. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John C. Minnerly Breakdown of academic impact, for papers by Artem Laktyushin Breakdown of academic impact, for papers by Esther P.M. Tjin Breakdown of academic impact, for papers by Paola Zancai Breakdown of academic impact, for papers by Nicholas C. Hsu Breakdown of academic impact, for papers by Lucía Cabal‐Hierro Breakdown of academic impact, for papers by Huihua Zhang Breakdown of academic impact, for papers by Patrice Hémon Breakdown of academic impact, for papers by Mark Tsang Breakdown of academic impact, for papers by Hirokazu Hirata
Rankless by CCL
2026